The integration of artificial intelligence (AI) in healthcare has been a topic of significant interest and research. One of the latest advancements in this field is Chat GPT Plus, an AI tool designed to assist physicians in making medical diagnoses. This article delves into a comprehensive study
In a groundbreaking study from the University of Toronto and The Hospital for Sick Children, published in JAMA, researchers have found that regular, self-reported symptom screening significantly reduces the overall symptom burden in pediatric cancer patients. This study adds to the growing body of
The ongoing battle against COVID-19 has led to numerous scientific breakthroughs, with one of the most promising being the inhibition of FasL (Fas ligand) to treat severe cases. This article delves into the impacts of FasL inhibition on the recovery and mortality of severe COVID-19 patients, based
Magnetic resonance imaging (MRI) is a cornerstone of modern medical diagnostics, offering detailed images of internal body structures. The technique relies on powerful magnets to map molecules like water and fat, but detecting other substances, such as metabolites, is challenging due to their low
In recent years, a noticeable shift has emerged in the realm of clinical cancer research, with pharmaceutical companies now playing a dominant role in funding and conducting trials. This transformation is evident in the stark contrast between industry and federal sponsorships. Between 2018 and
The rise of artificial intelligence (A.I.) in the pharmaceutical industry signifies a transformative period, placing unprecedented power in the hands of tech-driven drug discovery and igniting debates about innovation, control, and patient safety. Subject to regulatory scrutiny, the FDA has
